Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jared T Ahrendsen

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Journal of Neuropathology and Experimental Neurology|July 22, 2025
IDH-wildtype astrocytoma with FH mutation, epigenetic similarity to IDH-mutant astrocytoma, and hypermethylation of CDKN2A arising in the brainstemHeather L Smith, Drew J Duckett, Melissa Mejia-Bautista, et al.
Biorxiv : the Preprint Server for Biology|December 16, 2022
Superiority of intranasal over systemic administration of bioengineered soluble ACE2 for survival and brain protection against SARS-CoV-2 infectionLuise Hassler, Jan Wysocki, Jared T Ahrendsen, et al.
Life Science Alliance|April 11, 2023
Intranasal soluble ACE2 improves survival and prevents brain SARS-CoV-2 infectionLuise Hassler, Jan Wysocki, Jared T Ahrendsen, et al.
Journal of Neuropathology and Experimental Neurology|October 24, 2025
Rapid assessment of MGMT promoter methylation status by droplet digital polymerase chain reaction on intraoperative smear preparation: A proof-of-concept studyZachary Coty-Fattal, Heather Smith, Matthew McCord, et al.
Journal of Neuropathology and Experimental Neurology|January 11, 2025
Dual TERT promoter mutations in an oligodendroglioma, IDH-mutant, 1p/19q co-deletedMichael S Fernandopulle, Zachary Cotty-Fattal, Heather Smith, et al.
Journal of Neuro-Oncology|October 2, 2019
Increasing value of autopsies in patients with brain tumors in the molecular eraJared T Ahrendsen, Mariella G Filbin, Susan N Chi, et al.
Journal of Neuropathology and Experimental Neurology|July 31, 2024
Diagnostic utility of multimodal advanced molecular testing to classify metastases of unknown primaries: A case of a patient with no known medical historyHeather Smith, Jeffrey Jean, Drew Duckett, et al.
Frontiers in Oncology|November 17, 2022
An analysis of sexual dimorphism in the tumor microenvironment of colorectal cancerAndrea E Geddes, Anita L Ray, Robert A Nofchissey, et al.
Acta Neuropathologica Communications|December 30, 2025
Development, validation, and utility of a clinically applicable methylation classifier for recurrence risk prediction in meningiomasDrew Duckett, Lucas Santana-Santos, Matthew McCord, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 22, 2025
Leveraging chromatin packing domains to target chemoevasion in vivoJane Frederick, Ranya K A Virk, I Chae Ye, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Journal of Neuropathology and Experimental Neurology|July 22, 2025
IDH-wildtype astrocytoma with FH mutation, epigenetic similarity to IDH-mutant astrocytoma, and hypermethylation of CDKN2A arising in the brainstemHeather L Smith, Drew J Duckett, Melissa Mejia-Bautista, et al.
Biorxiv : the Preprint Server for Biology|December 16, 2022
Superiority of intranasal over systemic administration of bioengineered soluble ACE2 for survival and brain protection against SARS-CoV-2 infectionLuise Hassler, Jan Wysocki, Jared T Ahrendsen, et al.
Life Science Alliance|April 11, 2023
Intranasal soluble ACE2 improves survival and prevents brain SARS-CoV-2 infectionLuise Hassler, Jan Wysocki, Jared T Ahrendsen, et al.
Journal of Neuropathology and Experimental Neurology|October 24, 2025
Rapid assessment of MGMT promoter methylation status by droplet digital polymerase chain reaction on intraoperative smear preparation: A proof-of-concept studyZachary Coty-Fattal, Heather Smith, Matthew McCord, et al.
Journal of Neuropathology and Experimental Neurology|January 11, 2025
Dual TERT promoter mutations in an oligodendroglioma, IDH-mutant, 1p/19q co-deletedMichael S Fernandopulle, Zachary Cotty-Fattal, Heather Smith, et al.
Journal of Neuro-Oncology|October 2, 2019
Increasing value of autopsies in patients with brain tumors in the molecular eraJared T Ahrendsen, Mariella G Filbin, Susan N Chi, et al.
Journal of Neuropathology and Experimental Neurology|July 31, 2024
Diagnostic utility of multimodal advanced molecular testing to classify metastases of unknown primaries: A case of a patient with no known medical historyHeather Smith, Jeffrey Jean, Drew Duckett, et al.
Frontiers in Oncology|November 17, 2022
An analysis of sexual dimorphism in the tumor microenvironment of colorectal cancerAndrea E Geddes, Anita L Ray, Robert A Nofchissey, et al.
Acta Neuropathologica Communications|December 30, 2025
Development, validation, and utility of a clinically applicable methylation classifier for recurrence risk prediction in meningiomasDrew Duckett, Lucas Santana-Santos, Matthew McCord, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 22, 2025
Leveraging chromatin packing domains to target chemoevasion in vivoJane Frederick, Ranya K A Virk, I Chae Ye, et al.
Pageof 6